(RTTNews) -  Hagens Berman Sobol Shapiro said on Friday that the United States Court of Appeals for the First Circuit upheld an earlier District Court ruling on November 19, approving a settlement in the long-running Average Wholesale Price pharmaceutical litigation against AstraZeneca Pharmaceuticals (AZN: News ,AZN.L: News ).

The ruling affirms a settlement that awarded consumers who purchased the pharmaceutical giant's prostate cancer drug Zoladex treble damages, a rare if not unprecedented event in consumer litigation.
The case, argued by Steve W. Berman a Seattle plaintiff's attorney with Hagens Berman Sobol Shapiro, afforded thousands of consumers access to a $24 million settlement against the drug giant accused of manipulating the price of Zoladex.

Click here to receive FREE breaking news email alerts for AstraZeneca PLC and others in your portfolio

by RTT Staff Writer

For comments and feedback: contact editorial@rttnews.com